Brussels, 27/09/2001 (Agence Europe) - The G10 Medicines Group (of individuals representing the pharmaceutical industry, patients' associations and relevant government departments, set up in March 2001 on the initiative of Commissioner Erkki Liikanen (Industry) and David Byrne (Health and Consumer Protection) to consider how best to enhance the EU's pharmaceutical industry's competitiveness while safeguarding patient interests) has announced new transparency initiatives. It has agreed to...